SynthesisInternational journal of immunopathology and pharmacology

Novel anti-amyloid-beta (Aβ) monoclonal antibody lecanemab for Alzheimer's disease: A systematic review.

Selia Chowdhury et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.